UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036317
Receipt number R000041189
Scientific Title Effect of plant-derived lactic acid bacterium-fermented fruit juice powder on perennial allergy status
Date of disclosure of the study information 2019/03/28
Last modified on 2022/03/31 00:39:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of plant-derived lactic acid bacterium-fermented fruit juice powder on perennial allergy status

Acronym

Effect of plant-derived lactic acid bacterium-fermented fruit juice powder on perennial allergy status

Scientific Title

Effect of plant-derived lactic acid bacterium-fermented fruit juice powder on perennial allergy status

Scientific Title:Acronym

Effect of plant-derived lactic acid bacterium-fermented fruit juice powder on perennial allergy status

Region

Japan


Condition

Condition

Healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of powdered plant-derived lactic acid bacterium (Lactobacillus paracasei IJH-SONE68)-fermented fruit juice on perennial allergy state in subjects with allergic conditions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes from baseline of averaged self evaluation score about allergic conditions and VAS score in daily life difficulty.

These are measured at every 4 weeks interval until week 12.

Key secondary outcomes

Changes from baseline of averaged total serum IgE and semi-quantitative specific IgE (for house dust 1, house dust 2, allergenic Poaceae, wild weeds, animal dandruff, and fungi).

These are also measured at every 4 weeks interval until week 12.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Subjects receive 4 capsules (1000 mg) / day containing IJH-SONE68-fermented pineapple juice powder (sterilized) for 12 weeks.

Interventions/Control_2

Subjects receive 4 placebo capsules (1000 mg) / day containing dextrin powder for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Subjects
1) who feel allergic conditions, such as sneeze, nasal mucus, stuffy nose, itchiness of eyes, teary eyes, and dull headache.
2) whose self evaluation score is greater than or equal to 8 and lesser than or equal to 20.
3) whose VAS score is greater than or equal to 40.

Key exclusion criteria

1) Allergy to pineapple
2) Taking drugs for chronic disease
3) In pregnancy or nursing a child
4) Taking functional food that may affect the allergic conditions
5) Participation in any clinical trial with in 90 days of the commencement of the trial

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Masafumi
Middle name
Last name Noda

Organization

Hiroshima University, Graduate School of Biomedical & Health Sciences

Division name

Probiotic Science for Preventive Medicine

Zip code

734-8553

Address

Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan

TEL

082-257-5288

Email

bel@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Masafumi
Middle name
Last name Noda

Organization

Hiroshima University, Graduate School of Biomedical & Health Sciences

Division name

Probiotic Science for Preventive Medicine

Zip code

734-8553

Address

Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan

TEL

082-257-5288

Homepage URL


Email

bel@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Asahi Kohsan Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee of Hiroshima University

Address

Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan

Tel

082-257-5805

Email

kasumi-kenkyu@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学病院 (広島県)


Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 28 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

60

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 03 Month 06 Day

Date of IRB

2019 Year 03 Month 22 Day

Anticipated trial start date

2019 Year 05 Month 07 Day

Last follow-up date

2021 Year 08 Month 31 Day

Date of closure to data entry

2021 Year 09 Month 30 Day

Date trial data considered complete

2021 Year 09 Month 30 Day

Date analysis concluded

2021 Year 10 Month 31 Day


Other

Other related information

60 participants were already entered.


Management information

Registered date

2019 Year 03 Month 27 Day

Last modified on

2022 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041189


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name